Solaxa is a neuro-regenerative startup that develops novel and reformulated drugs to restore nerve function by targeting ion channels.
Solaxa has raised $670K in total funding. The most recent round was Seed. The last funding was announced in May 2024.
Solaxa is headquartered in Bethesda, United States.
Solaxa is a neuro-regenerative startup that develops novel and reformulated drugs to restore nerve function by targeting ion channels.
Solaxa is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Solaxa — Funding & Investors." VCBacked, May 3, 2024, https://www.vcbacked.co/company/solaxa. Accessed October 3, 2026.
VCBacked. (2024). Solaxa — Funding & Investors. Retrieved October 3, 2026, from https://www.vcbacked.co/company/solaxa
{{cite web |title=Solaxa — Funding & Investors |url=https://www.vcbacked.co/company/solaxa |website=VCBacked |access-date=October 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated